Termino C 11475 AB

ABDissolved

Org 5593226532Research and experimental development on biotechnology · NACE 7211Est. 20210 employees

Overview Financials People & ownership Related companies

Termino C 11475 AB is a Swedish AB, operating in the Bioteknisk forskning och utveckling sector. Incorporated in 2021, the company has 0 employees and reported revenue of SEK 6,8M in its latest annual filing.

Revenue 2023

SEK 6,8M

-1% vs 2022

EBITDA margin

12.9%

+58% vs 2022

Equity ratio

31.3%

Financial strength

Net profit 2023

SEK 344K

-1% vs 2022

EBITDA — year on year

SEK millions

Key figures

Annual report 2023

Revenue	SEK 6,8M	-1%
EBITDA	SEK 876K	+58%
Net profit	SEK 344K	-1%
Total assets	SEK 2,8M	+11%
Equity	SEK 882K	+64%
Employees	0	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Termino C 11475 AB?

Termino C 11475 AB is registered with Bolagsverket / SCB under Org 5593226532.

What is the revenue of Termino C 11475 AB?

Termino C 11475 AB reported revenue of SEK 6,8M in 2023.

Who is the CEO of Termino C 11475 AB?

Sara Elisabet Snogerup Linse is Deputy Chief Executive Officer of Termino C 11475 AB, in role since 2022.

Who is the chairman of Termino C 11475 AB?

Barton Thomas Henderson chairs the board of Termino C 11475 AB, in role since 2022.

Termino C 11475 AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Termino C 11475 AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Termino C 11475 AB